-
1.发明公开
公开(公告)号：EP3705491A1
公开(公告)日：2020-09-09
申请号：EP20170212.3
申请日：2016-07-14
IPC分类号： C07K14/47
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
2.发明公开
公开(公告)号：EP3322717A1
公开(公告)日：2018-05-23
申请号：EP16739102.8
申请日：2016-07-14
IPC分类号： C07K14/47
CPC分类号： A61K35/17 , A61K39/0011 , A61K2039/5158 , C07K7/06 , C07K7/08 , C07K14/4727 , C07K14/4748 , C07K14/7051 , C07K16/30 , C12N15/115 , C12N2310/16 , C12P21/02 , C12Q1/6881 , C12Q1/6886 , C12Q2600/136 , C12Q2600/156 , C12Q2600/158 , G01N33/57484 , G01N2333/70539 , G01N2500/04
摘要： The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
-
搜索结果
2 条记录 (耗时 0.013 秒)
